首页> 美国卫生研究院文献>Malaria Journal >Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline
【2h】

Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline

机译:恶性疟原虫小亚单位核糖体RNA基因突变与体外缺乏相关性降低对多西环素的敏感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDoxycycline is an antibiotic used in combination with quinine or artesunate for malaria treatment or alone for malaria chemoprophylaxis. Recently, one prophylactic failure has been reported, and several studies have highlighted in vitro doxycycline decreased susceptibility in Plasmodium falciparum isolates from different areas. The genetic markers that contribute to detecting and monitoring the susceptibility of P. falciparum to doxycycline, the pfmdt and pftetQ genes, have recently been identified. However, these markers are not sufficient to explain in vitro decreased susceptibility of P. falciparum to doxycycline. In this paper, the association between polymorphism of the small sub-unit ribosomal RNA apicoplastic gene pfssrRNA (PFC10_API0057) and in vitro susceptibilities of P. falciparum isolates to doxycycline were investigated.
机译:背景多西环素是与奎宁或青蒿琥酯组合用于治疗疟疾或单独用于疟疾化学预防的抗生素。最近,已经报道了一种预防性失败,并且一些研究强调了体外强力霉素降低了来自不同地区的恶性疟原虫分离株的敏感性。最近发现了有助于检测和监测恶性疟原虫对强力霉素的敏感性的遗传标记,pfmdt和pftetQ基因。但是,这些标志物不足以解释恶性疟原虫对强力霉素的体外敏感性降低。本文研究了核糖体小亚单位核糖体塑性基因pfssrRNA(PFC10_API0057)的多态性与恶性疟原虫分离株对强力霉素的体外敏感性之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号